Weekly 52-Week High Companies: Fidelity National Financial,

Fidelity National Financial Inc. (FNF) Reached the 52-Week High of $22.83

Fidelity National Title Group Inc. is a leading provider of title insurance, specialty insurance, and claims management services. FNF also provides flood insurance, personal lines insurance, and home warranty insurance through it specialty insurance business. Fidelity National Financial Inc. has a market cap of $4.91 billion; its shares were traded at around $22.83 with a P/E ratio of 207.5 and P/S ratio of 1.2. The dividend yield of Fidelity National Financial Inc. stocks is 2.6%.

Fidelity National Financial Inc. recently reported results for the quarter ended 12/31/08. Total revenue was $1.02 billion compared to $1.30 billion for the same period of 2007.

FNF is in the portfolios of Tom Gayner of Markel Gayner Asset Management Corp, Arnold Schneider of Schneider Capital Management, Richard Pzena of Pzena Investment Management LLC, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, John Keeley of Keeley Fund Management, Charles Brandes of Brandes Investment.

Sell: EVP & CFO Anthony Park sold 20,000 shares of FNF stock on 12/31/2008 at the average price of $17.67; the price of the stock has increased by 29.2% since. Sell: Executive Vice President Roger S Jewkes and Sell: EVP, Eastern Operations Christopher Abbinante both sold shares in March. Sell: Director William Lyon sold 306,377 shares of FNF stock on 02/17/2009, and Sell: Director William P II Foley sold 550,000 shares of FNF stock on 12/22/2008; the price of the stock has increased by 41.89% since.

Family Dollar Stores Inc. (FDO) Reached the 52-Week High of $34.33

Family Dollar Stores Inc. is one of the fastest growing discount store chains in the United States. Stores generally range in size from 6000 to 8000 square feet and most are operated under leases. Family Dollar Stores Inc. has a market cap of $4.8 billion; its shares were traded at around $34.33 with a P/E ratio of 20.1 and P/S ratio of 0.7. The dividend yield of Family Dollar Stores Inc. stocks is 1.5%. Family Dollar Stores Inc. had an annual average earning growth of 9.2% over the past 10 years. GuruFocus rated Family Dollar Stores Inc. the business predictability rank of 3-star.

On April 8, 2009, Family Dollar Stores Inc. reported results for the quarter ended 2/28/09. Net income for the second quarter increased 32.9% to $84.1 million compared with net income of $63.3 million for the second quarter of fiscal 2008.

FDO is in the portfolios of Richard Aster Jr of Meridian Fund.

Sell: Executive Vice President Barry W Sullivan sold 7,123 shares of FDO stock in February and the price of the stock has increased by 18.38% since. Sell: Executive Vice President Charles S Jr Gibson sold 82,666 shares of FDO stock in February; the price of the stock has increased by 18.38%. Sell: Director Sharon A Decker , Sell: Senior Vice President Charles M Sowers and Sell: Senior Vice President Janet G Kelley sold shares in January and the price per stock has increased by over 20% since.

Mylan Laboratories Inc. (MYL) Reached the 52-Week High of $14.21

Mylan Inc. is one of the world’s leading quality generic and specialty pharmaceutical companies. The company offers one of the industry’s broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Mylan Laboratories Inc. has a market cap of $4.33 billion; its shares were traded at around $14.21 with a P/E ratio of 19.2 and P/S ratio of 0.8. Mylan Laboratories Inc. had an annual average earning growth of 16.8% over the past 10 years. GuruFocus rated Mylan Laboratories Inc. the business predictability rank of 2.5-star.

Mylan Laboratories Inc. recently reported total revenues of $1.20 billion for the three months ended Dec. 31, 2008, an increase of $47.8 million over the same prior year period . MYL is in the portfolios of David Dreman of Dreman Value Management, Charles Brandes of Brandes Investment, George Soros of Soros Fund Management LLC. Recent

Buy: Vice Chairman, CEO Robert J Coury bought 50,000 shares of MYL stock in February; the price of the stock has increased by more than 9%. Buy: Director Rodney L Piatt also bought 5,000 shares in February and Sell: Exec. VP, Global Tech. Ops. Rajiv Malik sold 5,690 shares of MYL stock in March.

Myriad Genetics Inc. (MYGN) Reached the 52-Week High of $45.48

Myriad Genetics Inc. uses gene-based medicine to develop therapeutic and molecular diagnostic products. The company employs a variety of proprietary proteomic technologies to discover disease genes and to understand the role these genes and their related proteins play in the onset and progression of disease. Myriad Genetics Inc. has a market cap of $4.32 billion; its shares were traded at around $45.48 with a P/E ratio of 44.7 and P/S ratio of 12.9.

On February 3, 2009, Myriad Genetics announced results of their second quarter for fiscal year 2009. The company recorded a net profit of $21.2 million, compared to a net loss of $5.1 million in the same quarter of the prior year. Product revenues rose to $84.0 million from $53.1 million in the same three months of the prior year.

Sell: CFO James S Evans sold 21,928 shares of MYGN stock in February at the average price of $40.01; the price of the stock has increased by 13.67% since. Sell: COO, MGL Mark Christopher Capone sold 79,786 shares of MYGN stock total in February and April. Sell: COO, MPI W Wayne Laslie and Sell: Executive V.P. - Research Jerry S Lanchbury both sold shares in March.

HCC Insurance Holdings Inc. (HCC) Reached the 52-Week High of $27.12

HCC Insurance Holdings Inc. provides specialized property & casualty insurance coverages, managing general agency services, & insurance related services both to commercial customers & individuals. HCC Insurance Holdings Inc. has a market cap of $3.08 billion; its shares were traded at around $27.12 with a P/E ratio of 9.5 and P/S ratio of 1.3. The dividend yield of HCC Insurance Holdings Inc. stocks is 1.8%. HCC Insurance Holdings Inc. had an annual average earning growth of 15.5% over the past 10 years. GuruFocus rated HCC Insurance Holdings Inc. the business predictability rank of 2.5-star.

HCC Insurance Holdings Inc. recently reported financial results for the quarter ended 12/31/08. Net earnings for the fourth quarter of 2008 were $72.3 million, compared to $99.6 million for the fourth quarter of 2007.

HCC is in the portfolios of John Rogers of ARIEL CAPITAL MANAGEMENT LLC, John Keeley of Keeley Fund Management, David Dreman of Dreman Value Management.

Sell: Executive Vice President & CFO, Director Edward H Jr Ellis sold 62,000 shares of HCC stock total throughout November and December; the price of the stock has increased by 10.6% since his last sell. Buy: President & COO John Niels Jr Molbeck bought 100 shares of HCC stock on last month; the price of the stock has increased by 33.93% since. Buy: Director Thomas M Hamilton and Buy: Director James E Oesterreicher both bought shares in December. Sell: Director James C Flagg and Sell: Director Michael A F Roberts sold shares of HCC the same month; the price of the stock has increased by more than 14% since.